• 2021 Asia and China outlook - media briefing highlights (with playback)
Investment Institute
Annual Outlook

2021 Asia and China outlook - media briefing highlights (with playback)

  • 14 January 2021 (5 min read)

Following an unparalleled twelve months, we have entered 2021 with some light at the end of the tunnel. The arrival of vaccines will hopefully mean a swift reopening of economies, and a potential broad-based cyclical rally in risk assets.

At a media briefing on 12 January (with playback video below), AXA IM’s economist and investment experts discussed what a post-coronavirus, “new-normal” world would look like – and outlined the possible implications for China’s economy, Asian equity and credit markets, and the fast-growing ESG investing space.

1) China Macro


Aidan YAO, Senior Emerging Asia Economist

Overarching theme – “Back to Normal”

  • The macro trajectory will be driven by the normalisation of public health conditions, the real economy and Beijing’s policies.
  • As growth momentum recovers with laggards catching up, we look for a marked acceleration of annual GDP growth to 8% in 2021, with risks tilting slightly to the upside.
  • Economic policies are also on path to normalisation, although Beijing will do so in a cautious manner to ensure policy “continuity, stability and sustainability” and avoid “sudden turns” in policy changes that induce unnecessary economic volatility.
  • The renminbi will likely remain strong this year. However, with countries resuming production activities and vaccines approved, China’s trade surplus may decrease, and the US-China interest rate spread may narrow, limiting the yuan’s upward trend. We expect the USD/CNY rate to range from 6.4 to 6.5 this year.

Biden presidency and US-China relations

  • Biden’s priority will be domestic issues including battling the pandemic and stimulating the economy. Nonetheless, the Biden administration will likely bring more predictability to foreign policies that would help restore some calmness in the bilateral relationship, particularly in relation to trade.
  • However, competition in core technologies and financial dominance will likely continue, so will frictions in geopolitics in the region.

China’s 14th Five Year Plan – Four main objectives

  • Achieving self-reliance on core technologies and critical supply-chains, which requires China to invest in R&D to spur organic innovation and move up the production chain;
  • Pursuing sustainable and high-quality growth, which requires China to continue urbanisation and foster growth in the middle-class;
  • Combating climate change and cleaning up the environment, underlined by goals to achieve peak carbon emission by 2030 and carbon neutrality before 2060;
  • Continuing to liberalise the economy (by joining high-standard trade/investment agreements, such as RCEP, CN-EU CAI and potentially CPTPP) and financial system (by increasing accessibility to the onshore markets and internationalising the yuan).

2) Asian Equities


 Simon Weston, Senior Portfolio Manager, Asian Equities

Overall outlook for Asian equities

  • We maintain a positive outlook as recovery is expected to continue, helped by the external sector with developed markets also experiencing a rebound as vaccines are rolled out, leading to an increase in demand for Asian exports.
  • More generally, we should see normalisation of activity, which should provide a boost to those areas most affected by the virus such as travel and hospitality.

Chinese stocks remain attractive

  • Chinese stocks remain attractive within an Asian context given that the country’s recovery is furthest advanced within the region, and especially “new economy” sectors that have been the biggest beneficiary of the impact of the pandemic, e.g. e-commerce.
  • We would expect to see a greater focus on areas such as healthcare, which will increase investor interest in these sectors.  Policy initiatives such as the drive for renewable energy are also generating new investment opportunities.
  • There has been some increase in regulatory risk in certain sectors, most obviously in fintech, and alleged monopoly-type behaviour by some of the internet giants is also getting regulatory scrutiny, but in the longer term this should be positive and shouldn’t detract from the underlying strength of these sectors.

A-shares continue to attract foreign investors

  • The role of Hong Kong as an important financial centre for China has been further demonstrated in 2020 with a number of big names doing a secondary listing in the HKEX.  Uncertainty around the regulatory environment for Chinese companies listed in the US is likely to further enhance the attraction of Hong Kong’s bourse as a listing destination for Chinese companies relative to other exchanges.
  • A-shares will likely continue to attract interest from foreign investors as the latter become more familiar with the routes to investing and also as knowledge of the market grows. Enhanced research coverage from global investment banks of the A-share market is also providing more confidence to foreign investors.

Long-term structural opportunities

  • We have always pursued an investment strategy that is focused on long-term structural growth opportunities, and to a large extent the pandemic has validated many of them and accelerated those structural shifts, e.g. e-commerce and healthcare.
  • Tech has been a big part of this, which fits with our view that an overarching trend generally has been towards the growing ubiquity of tech in all aspects of our lives, and again this has been confirmed as a consequence of the pandemic.
  • Some specific sectors have benefited directly from the WFH phenomenon, and although some of this demand may have been one-off in nature, the fact that we are now talking about new ways of working – facilitated by tech – reinforces expectations that tech will continue to play a bigger role in our lives.  The further rollout of 5G and IoT will also see an increase in opportunities.
  • Thus, against this background we expect tech to remain a key investment focus.

3) Asian Credits



Jim Veneau, Head of Asian Fixed Income

Macro backdrop and overall outlook

  • Despite the surge in COVID-19 infections and more countries under lockdowns, the macro backdrop has turned positive on the back of encouraging vaccine developments and stimulus expectations.
  • One of the key drivers for Asian credit spreads to tighten further from current levels is the continued search for yield by global investors, which is becoming more challenging.
  • Negative yielding bonds have risen to $16.5 trillion globally, accounting for a quarter of the global fixed income market.
  • A rapid rise in US treasury yields, say 100bps, which happened during the Taper Tantrum in 2013 and again after Trump's 2016 election, would be very disruptive to emerging markets. However, we are not expecting that this year.

Positioning – Buy-side’s perspective

  • Coupled with risk to the upside for US Treasuries, we look to remain short/underweight duration, selectively add high yield (HY) credit, the recent weakness of which offers some relative value, and incrementally add unhedged local currency exposure (rates and/or credit).
  • Strong new issue pipeline will create some tactical opportunities, as will binary, funding-driven distressed recoveries. Actively take profit on overbought names, and cut loss on losers.
  • High yield vs. Investment Grade
  • Although we have a preference for Asian HY due to a spread pick-up of over 400bps compared to Asian Investment Grade (IG), we note that the pandemic has exposed weaker credits and resulted in greater credit differentiation.
  • BB HY corporates and IG broadly are expensive but stable.

Opportunities in 2021

  • Indonesian corporates should continue to compress, as should high-beta HY China property, while caution should be taken with highly leveraged, funding challenged names. As for IG, some opportunities remain in a few sectors, mainly in China.
  • As seen in the recent defaults in China’s onshore market, the country’s state-owned enterprises (SOEs) were not spared.
  • Despite ample liquidity in the banking system and bond markets, investors and banks have taken a cautious approach and become even more selective.
  • Therefore, potential government support for zombie SOEs in non-strategic sectors should not be taken for granted.

4) ESG Investing



Anubhuti Guptam, Head of Investments APAC, Rosenberg Equities

ESG investing – Trends and performance

  • We are seeing demand for ESG investing accelerate amid COVID-19, as investors, individuals and institutions alike, are looking for solutions that will deliver resilience that is necessary to navigate uncertain market conditions.
  • As efforts to combat climate change galvanise, investors are beginning to switch from simple commitments to tangible actions. Fresh attention has fallen on social issues such as public health, human capital management and societal inequalities.
  • Our analysis of both stock and bond markets in Q1 2020 show that companies that are ahead of their peers in terms of ESG ratings have proven more resilient in the coronavirus market crash than those with the lowest ratings.

Investment opportunities

  • A structural change is occurring. In the past, ESG investing was more about mitigating risk, but today it is also about seizing opportunities.
  • We believe investors can drive positive social outcomes and generate robust long-term returns through investments in different asset classes and active ownership and engagement.
  • We believe Green bonds, thematic equities, ESG integration, listed impact and dedicated carbon reduction investment strategies present attractive value propositions. We see the nascent COVID-19 bonds market as a potential new area for impactful debt issuance.
  • However, lack of standard definitions, wide range of investor preferences and the sheer breadth of the ESG space pose challenges to investors to separate the wheat from the chaff.

“Genuine” ESG investments – What to look out for:

  • A clear articulation of the ESG strategy and philosophy and how it translates into company policy and investment strategy;
  • Resources invested in ESG – dedicated ESG analysts and experts, data, training, individual and collective engagement, participation in organisations like UN PRI, CDP, etc.
  • Measurement and reporting of relevant ESG KPIs for the strategy
  • As an example, for COVID-19 bonds, AXA IM has developed an investment framework that expects transparency from issuers around how proceeds will be used to support their response to the pandemic. We also call for a commitment to outcome and impact measurement.


    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This promotional communication does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee that forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.

    The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.


    This website is published by AXA Investment Managers Asia Limited (“AXA IM HK”), an entity licensed by the Securities and Futures Commission of Hong Kong (“SFC”), for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy, sell or enter into any transactions in respect of any investments, products or services, and should not be considered as solicitation or investment, legal, tax or any other advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities under any applicable law or regulation. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation, investment knowledge or particular needs of any particular person and may be subject to change at any time without notice. Offering may be made only on the basis of the information disclosed in the relevant offering documents. Please consult independent financial or other professional advisers if you are unsure about any information contained herein.

    Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee such opinions, estimates and forecasts made will come to pass. Actual results of operations and achievements may differ materially. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Information herein may be obtained from sources believed to be reliable. AXA IM HK has reasonable belief that such information is accurate, complete and up-to-date. To the maximum extent permitted by law, AXA IM HK, its affiliates, directors, officers or employees take no responsibility for the data provided by third party, including the accuracy of such data. This material does not contain sufficient information to support an investment decision. References to companies (if any) are for illustrative purposes only and should not be viewed as investment recommendations or solicitations.

    All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and that past performance is no guarantee of future returns, investors may not get back the amount originally invested. Investors should not make any investment decision based on this material alone. 

    Some of the services listed on this Website may not be available for offer to retail investors.

    This Website has not been reviewed by the SFC. © 2022 AXA Investment Managers. All rights reserved.